4//SEC Filing
Sucampo Pharmaceuticals, Inc. 4
Accession 0001209191-15-031737
CIK 0001365216operating
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 5:49 PM ET
Size
8.5 KB
Accession
0001209191-15-031737
Insider Transaction Report
Form 4
Ueno Ryuji
DirectorCEO, Chief Scientific Officer10% Owner
Transactions
- Sale
Class A Common Stock
2015-03-31$14.00/sh−1,186,113$16,605,582→ 20,274,689 total(indirect: By LLC) - Sale
Class A Common Stock
2015-03-31$14.00/sh−60,357$844,998→ 0 total(indirect: By Spouse) - Sale
Class A Common Stock
2015-03-31$14.00/sh−353,530$4,949,420→ 0 total
Footnotes (3)
- [F1]The sales reported on this Form 4 were effected as part of an underwritten public offering in which the reporting person, his wife and S&R Technology Holdings, LLC each participated as a selling stockholder.
- [F2]Dr. Ueno disclaims beneficial ownership of the reported securities.
- [F3]S&R Technology Holdings, LLC is wholly owned by Dr. Ueno and his wife. Dr. Ueno disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Documents
Issuer
Sucampo Pharmaceuticals, Inc.
CIK 0001365216
Entity typeoperating
Related Parties
1- filerCIK 0001365216
Filing Metadata
- Form type
- 4
- Filed
- Apr 1, 8:00 PM ET
- Accepted
- Apr 2, 5:49 PM ET
- Size
- 8.5 KB